Nuveen Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $54.1M | Sell |
1,798,989
-232,335
| -11% | -$6.99M | 0.02% | 619 |
|
2024
Q3 | $47.5M | Buy |
2,031,324
+342,673
| +20% | +$8.02M | 0.01% | 689 |
|
2024
Q2 | $30M | Buy |
1,688,651
+135,161
| +9% | +$2.4M | 0.01% | 875 |
|
2024
Q1 | $23.6M | Buy |
1,553,490
+202,769
| +15% | +$3.08M | 0.01% | 1077 |
|
2023
Q4 | $23.1M | Buy |
1,350,721
+968,611
| +253% | +$16.5M | 0.01% | 1058 |
|
2023
Q3 | $3.19M | Sell |
382,110
-2,030
| -0.5% | -$17K | ﹤0.01% | 2091 |
|
2023
Q2 | $9.54M | Sell |
384,140
-139,197
| -27% | -$3.46M | ﹤0.01% | 1535 |
|
2023
Q1 | $7.87M | Sell |
523,337
-81,810
| -14% | -$1.23M | ﹤0.01% | 1632 |
|
2022
Q4 | $7.16M | Buy |
605,147
+83,118
| +16% | +$983K | ﹤0.01% | 1704 |
|
2022
Q3 | $3.09M | Buy |
522,029
+144,022
| +38% | +$852K | ﹤0.01% | 2162 |
|
2022
Q2 | $1.61M | Sell |
378,007
-19,552
| -5% | -$83.1K | ﹤0.01% | 2549 |
|
2022
Q1 | $3.86M | Sell |
397,559
-64,499
| -14% | -$626K | ﹤0.01% | 2192 |
|
2021
Q4 | $7.22M | Sell |
462,058
-237,061
| -34% | -$3.71M | ﹤0.01% | 1882 |
|
2021
Q3 | $21.9M | Buy |
699,119
+40,587
| +6% | +$1.27M | 0.01% | 1208 |
|
2021
Q2 | $25.5M | Sell |
658,532
-18,077
| -3% | -$701K | 0.01% | 1180 |
|
2021
Q1 | $32.6M | Sell |
676,609
-71,995
| -10% | -$3.47M | 0.01% | 981 |
|
2020
Q4 | $38.9M | Buy |
748,604
+5,720
| +0.8% | +$298K | 0.01% | 835 |
|
2020
Q3 | $19.9M | Buy |
742,884
+313,670
| +73% | +$8.39M | 0.01% | 1068 |
|
2020
Q2 | $8.36M | Sell |
429,214
-203,499
| -32% | -$3.96M | ﹤0.01% | 1608 |
|
2020
Q1 | $6.23M | Buy |
632,713
+319,255
| +102% | +$3.14M | ﹤0.01% | 1581 |
|
2019
Q4 | $3.48M | Buy |
313,458
+15,450
| +5% | +$171K | ﹤0.01% | 2175 |
|
2019
Q3 | $1.67M | Buy |
298,008
+1,822
| +0.6% | +$10.2K | ﹤0.01% | 2484 |
|
2019
Q2 | $2.56M | Buy |
+296,186
| New | +$2.56M | ﹤0.01% | 2312 |
|